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LETTER TO THE EDITOR
Rationalizing the cost of anaesthesia in Zimbabwe: a proposal
MT CHIKUNGWA
Introduction
With the worsening economic situation in the country, it is 
only prudent to develop ‘survival strategies’ in order to 
keep afloat . Under such hardships human behaviour 
manifests the jungle rules of ‘survival of the fittest’. That 
is exactly what is happening particularly in the health 
sector, as I will highlight in this letter. The importation of 
medical drugs in Zimbabwe is controlled, but their resale 
is liberalized. The same anaesthetic drug may cost a 
hospital two to three times more by buying it from one 
company than from the other as shown below (Table I). 
This information is from an unpublished survey of the 
buying patterns of three hospitals and two public hospital 
pharmacies.
Strategies to Cut Down Costs in Anaesthesia.
I would like to share my own view on what I see as 
strategies for rationalizing anaesthetic drugs and accessories
use, which would result in cost saving. The strategies are 
divided into two: those relating to the hospital and those for 
the Anaesthetist.
Table I. Cost of drugs ( in Z$ ) bought by three hospitals 
from three different companies.
Drug Hospital A Hospital B Hospital C
Etomidate $408.75 $350.32  ^ $398.82
Thiopentone $121.70 $111.88 $132.28
Propofol $331.29 $284.66 $397.20
For Hospitals.
Anaesthetic Drugs Committee: A hospital should have 
an anaesthetic drug use committee comprising of the chief 
pharmacist and two or three anaesthetists. This committee 
could meet once or twice a month and formulate the 
hospital anaesthetic drug cost saving strategies. The 
advantage of this small committee is that they will highlight
to the pharmacist where a wastage is avoidable and what 
drugs not to buy in bulk.
A case in point is the large stocks of etomidate which 
some hospitals have, yet this intravenous anaesthetic drug 
is not used frequently and costs more than Abbott propofol 
which is the drug of choice for most procedures.
Anaesthetic Intravenous Induction Agents: Propofol 
has become much cheaper now since the patent ran out. 
Hospitals would do better having large stocks of propofol 
than etomidate. Where day surgery is the main activity of 
the hospital, there should be only a few vials of thiopentone 
and etomidate, but large stocks of the ideal agent propofol. 
For inpatients, anaesthetists should, as a matter of hospital 
policy, be encouraged to use the cheapest anaesthetic 
intravenous induction agent like thiopentone. There is not 
much benefit in using propofol for induction in a patient 
having a gastrectomy or posterior fossa tumour. For all 
non-day surgery patients, where thiopentone is used, the 
hospital saves about $125 per patient.
This sounds like a pittance but if you multiply this by 
three to five patients per list having major surgery and then 
considering that there are in most cases two lists per day 
multiplied by five days per week this comes to a saving of 
between $3 750 to $6 250 per week.
Inhalational Agents: Halothane is still the mainstay of 
anaesthesia in Zimbabwe. Isoflurane has several advantages 
over halothane, although it is much more expensive. I 
would recommend that every hospital keep Isoflurane in 
reserve for those special cases when it is needed. A few 
private hospitals are now using Isoflurane routinely. Of 
course they recover their money from the patient, but this 
might incur shortfalls on the patient’s medical bills when 
the medical aid societies pay the hospital, thus loading 
unnecessary financial burden on the patient.
Sevoflurane has excellent induction and recovery 
properties especially in paediatric anaesthesia. I would 
strongly recommend that when used, it should be for the 
shortest possible time i.e. stopped as soon as anaesthesia is 
induced, because it is still extremely expensive to be used 
for maintenance of anaesthesia..
Neuromuscular Blockers: New muscle relaxants are 
being released on the market e.g rocuronium and 
rapacuronium. These are meant to replace the depolarizing 
neuromuscular blocker suxamethonium. The truth is they 
are close but not as good as suxamethonium for the 
intended purpose. Therefore there is no economic sense in 
bulk buying these drugs instead of suxamethonium -  
which is much cheaper. There are also few special 
indications for atracurium which is slightly more expensive 
than the older alcuronium. Therefore a hospital, especially 
the public hospitals, would save a lot and keep it simple, by 
buying suxamethonium and alcuronium and making sure 
that there is a constant supply.
For The Anaesthetist.
Gloves: Non sterile gloves are recommended for canulation, 
intubation and extubation. Hospitals cannot charge for 
these gloves as they fall into the category of non-chargeables
(or non-tariff) items. If you use three pairs (conservative 
estimate) per patient i.e. for canulation, intubation, 
extubation and on a long list e.g. ENT list of 15 patients, 
this totals to 45 pairs per anaesthetist per list. I would 
advise cutting down on the number of pairs of gloves used 
per patient by simply keeping unsoiled gloves (e.g after 
canulation) for the intubation etc. These can be removed 
and kept for the next procedure on the same patient. They 
can also be cleaned by simply washing the gloved hands 
with soap and water for future use.
Needles: The anaesthetist can use a minimum number of 
needles per list by simple, good planning when preparing 
drugs. For example-for a day surgical list with six patients 
-  the anaesthetist may choose these drugs, morphine, 
droperidol, lignocaine and propofol. First use a 19G needle 
to draw up the morphine and droperidol in different syringes 
then draw up 1ml 2% lignocaine in six to 20ml syringes, 
finally use the same needle to draw up the propofol into the 
20ml syringes. Thus by simply planning like this the 
anaesthetist has saved 23 needles. Again if this is calculated 
per list in a busy hospital there is a big potential for saving. 
A single 19G needle costs about $2.50.
Analgesic Drugs: For a paediatric minor surgery list a 
lot of saving can be done by simply diluting potent drugs 
like the 15mg morphine per ampoule to 1 mg/ml with water 
for injection or saline. The average intravenous dose of 
morphine is 0. lmg/kg and therefore most paediatric patients 
will need 0.5 to 5mg intravenous injection. All that is 
needed is the diluted morphine to be put in one or 2ml 
syringes for the individual patients. Thus one ampoule of 
morphine can service a long paediatric list without any risk 
of contamination. Pethidine, fentanyl and the antiemetic 
droperidol could be used in a similar fashion as the dosages 
required are small.
Anaesthetic Gases: The use of low flow anaesthesia has 
been shown to cut down costs. Hospitals should encourage 
anaesthetists to use low flows by providing anaesthetic 
machines with a circle system, eapnography and anaesthetic 
agent monitor. Low flow anaesthesia is a specialized 
technique which requires learning and experience. 
Experienced anaesthetists should teach colleagues and 
juniors on this cost saving practice.
It is not surprising to find a gas flow of six to lOL/minute 
running for the entire period it takes to do a posterior fossa 
tumour for example, yet low flows of one to 3L/minute 
could be used and with good monitors, even lower than this 
with massive savings on the anaesthetic gases.
Also of paramount importance is for the Anaesthetist to 
always ensure that gases are turned off before leaving the 
theatre. In one incident, I discovered as I checked the 
anaesthetic machine before the morning list that it was 
running with a gas flow of 9L/minute of oxygen. On 
investigation it transpired that the machine was left running 
by a senior house officer after an em ergency 
appendicectomy done at 21 00 hours the previous night. 
This translates to a anaesthetic gas waste of 5 940L. What 
a waste !!
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Choice o f Anaesthesia: There are many advantages for 
choosing regional anaesthesia over general anaesthesia 
for most of the operative procedures below the umbilicus. 
Intra-operative cost for subarachnoid block (SAB), for 
example for Caesarean Section delivery is Z$383.50 which 
is three to four times cheaper than general anaesthesia 
(GA) as shown in Table II.
Table II: General anaesthesia vs spinal block for 
Caesarean Section delivery.
G .A S.A .B .
Tracheal tube 145.00 sterile gloves 13.00
Thiopactine & 20ml syringe 100.00 + 7.50 Spinal Needle (25G) 10.50
Suxamethonium + 2ml Syringe 130.00+3.00 Bupivacaine (Plain) 100.00
Alcuronium + 5ml Syringe 80.00 + 4.00 Spinal Pack (Laundry &
Halothane/45 min 300.00 Sterilizing) 60.00
Nitrous oxide/45 minutes 120.00 Ephedrine 200.00
Neostigmine + 5m 
+Atropine
Morphine + 2m! Syringe
70.00 + 4.00
45.00
50.00
Tota l 383 .50
To ta l 1 060.00
Items common to both types of anaesthesia have not been included in the 
costing. It is obviously a big cost saving move for the hospital to promote 
and for the anaesthetist to choose regional block than general 
anaesthesia.
Concentrated drugs (Morphine 15mg/ml, Droperidol 
5mg/2ml, Midazolam 15mg/3ml etc): In most cases only 
a quarter to three quarters of these constitute an average 
intra-operative dose. By diluting these drugs to lmg/ml, a 
more accurate amount is given and the remainder given to 
the next patient(s) provided sterile syringes are used to 
draw up the drug from the main syringe of dilute solution. 
With this technique the risk of contamination is no more 
than the risk of breaking a new ampoule of the same drug. 
As already pointed out, one ampoule of droperidol, for 
example, diluted to 0.5mg/ml (i.e 2ml of droperidol with 
5mg, made up to 10ml with saline) will provide enough 
antiemetic cover for a whole long list as the average dose 
is 125 to lOOOmcg droperidol depending on size of patient 
(children or adult).
In conclusion, these are some measures which both 
hospitals and anaesthetists can take to cut down the cost of 
anaesthesia without compromising the safety of the patient. 
This should apply for private and public sectors.
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